Medical News Today -
8 Dec 2013 10:00
Imetelstat, a novel telomerase inhibiting drug, has been found to induce morphologic, molecular and clinical remissions in some patients with myelofibrosis a Mayo Clinic study has found. The results were presented at the 2013 American Society of Hematology Annual Meeting in New Orleans."These are early results but they are promising, says the study's lead author, Ayalew Tefferi, M.D. a hematologist at Mayo Clinic.
Share this Article